Copernicus Therapeutics, Inc. Email Format

Biotechnology ResearchOhio, United States2-10 Employees

Copernicus Therapeutics, Inc. is a clinical-stage biotechnology company focused on genomics medicines, based in Cleveland, Ohio. The company uses a proprietary non-viral nucleic acid delivery platform, STELLAR, which can carry large payloads and enables receptor-mediated gene transfer while aiming to avoid the immune response typically associated with AAV vectors. It also relies on intellectual property around plasmid design to support long-term and controlled gene expression, with the goal of advancing genomic and precision medicine. Its current programs include Cystic Fibrosis (Phase I/II Complete), as well as pre-clinical work in Eye and Brain indications, and the firm traces its origins to technologies developed at Case Western Reserve University in Cleveland, reflecting a Northeast Ohio connection. The company reports revenue in the range of $10 million to $25 million.

Get verified Copernicus Therapeutics, Inc. emails free

Company overview Employee directory